Why 10 sen? Any news?

Phase IV refers to post registration clinical trial of exisiting registered polio vaccine. They are proposing to add a new indication to the registered poliio vaccine for prevention of Covid.

The arrival of the first COVID-19 vaccine will not mean people can throw their masks away, experts say.

Face coverings, social distancing and rigorous hand-washing still will be required for some time. How long depends on factors including how good the vaccines are and how long protection lasts — questions that will not be answered when the first shots arrive.

https://www.voanews.com/covid-19-pandemic/coronavirus-measures-will-not-end-when-vaccine-arrives-experts-say

Facial Mask Market Size to Reach Revenues of over USD 13 Billion by 2025 - Arizton

https://finance.yahoo.com/news/facial-mask-market-size-reach-130000585.html

See how it goes on Friday. For some reason the operator is purposely pressing down the price without any logic.

Sigh Dow Jones Drop quite a lot. Hopefully price will not drop any further on Friday. Hope it’s stable around this price.

@BigPortfolio No need to be so dramatic. Everyone has their own trading plans and risk appetites. You have your own. So to each its own.

@huatkopi88 Quite obvious got some sydicate manipulating the prices.

Crucial Covid vaccine data expected from Pfizer this week now unlikely to come before U.S. election

https://www.google.com/amp/s/www.cnbc.com/amp/2020/10/27/crucial-covid-vaccine-data-expected-from-pfizer-this-week-now-unlikely-to-come-before-us-election.htm

l Pfizer not yet ready to release Covid-19 vaccine data

https://www.theedgemarkets.com/article/pfizer-not-yet-ready-release-covid19-vaccine-data

@reezdragon85 You have point there. We are at the mercy of sharks but hopefully things will turn around soon.

Biden win will be good for China.

--------

Democratic challenger Joe Biden is currently leading Donald Trump in the national polls as the US approaches its 2020 presidential election.

https://www.telegraph.co.uk/news/2020/10/27/us-election-polls-2020-live-tracker-who-win-biden-trump/

S'porean expert on US politics says Biden will win election

https://mothership.sg/2020/10/us-election-biden-win-expert/

A Biden win could be bullish for the Chinese yuan, analysts say

Biden has slammed the trade war with China — saying that tariffs have hurt American businesses and consumers.

https://www.cnbc.com/2020/10/21/joe-biden-win-impact-on-trade-war-tariffs-chinese-yuan.html

Egypt set to be a distribution hub for coronavirus vaccines

According to Malsin, Chinese officials have previously stated China’s desire to make the country a hub for manufacturing and distributing vaccines in the African market.

In September, the Chinese company Sinopharm struck a deal with Egypt’s VACSERA to conduct human trials of a coronavirus vaccine manufactured in China.

Egypt is the fourth country to conduct tests on potential Chinese vaccines, in addition to UAE, Bahrain and Jordan.

Health Minister Hala Zayed injected herself with the vaccine in two stages in September and October, in order to encourage the recruitment of volunteers.

The vaccines made in China are expected to be cheaper and could be a readily available alternative to vaccines from Europe and the United States

https://www.egyptindependent.com/wsj-egypt-set-to-be-a-distribution-hub-for-coronavirus-vaccines/

SinoPharm (China): Currently testing about 15,000 volunteers in the Middle East in a trial the state-owned company expects to last three to six months. Early results suggest the drug is safe and at least somewhat effective. SinoPharm recently built a SECOND FACILITY to manufacture the vaccine, doubling its capacity to about 200 million doses per year.

CanSino Biologics (China): Set to begin large-scale human trials this summer, CanSino's vaccine has already been approved for the Chinese military. The vaccine is based on a modified common cold virus, which some experts warn could make it LESS EFFECTIVE than other vaccine efforts.

https://www.reuters.com/article/us-health-coronavirus-china-vaccine/chinas-sinopharm-unit-completes-new-covid-19-vaccine-plant-doubles-capacity-idUSKBN2424IU

Novavax delays U.S. trial start of COVID-19 vaccine to November

https://leaderpost.com/pmn/business-pmn/novavax-delays-u-s-trial-start-of-covid-19-vaccine-to-november

Russian Vaccine : Reality bites for Putin's much-hyped Covid-19 vaccine, as concerns over efficacy and safety linger

https://edition.cnn.com/2020/10/27/health/russia-coronavirus-vaccine-sputnik-v-reality-check/index.html

@Noobie123 yes you are right.

https://www.theedgemarkets.com/article/kanger-courted-uae-firm-jointly-set-glove-outfit-malaysia

https://www.theedgemarkets.com/article/kanger-seeks-rights-distribute-chinadeveloped-covid19-vaccine-southeast-asia

Looks like Sinopharm vaccine is well positioned to overtake Sinovac vaccine in the global covid vaccine race at this rate as Brazil's president is blocking the imporation of Sinovac vaccine and getting in the way of the Phase III trial.

-----
Politics upends search for Covid vaccine in Brazil

"Brazil is a top testing ground for vaccines against Covid-19, but its plans for vaccinating its own population have been plunged into chaos by a political war waged by President Jair Bolsonaro.

Hit hard by the new coronavirus, Brazil has been tapped to help test several of the leading vaccine candidates, giving it a potential edge in the race to secure access to an eventual shot.

That could be a welcome silver lining for the country of 212 million people, which has the second-highest Covid-19 death toll in the world, at more than 157,000.

But one promising test vaccine, developed by Chinese pharmaceutical firm Sinovac Biotech, has triggered the ire of the far-right president, who last week CANCELLED HIS HEALTH MINISTER'S PLAN to buy 46 million doses.

The vaccine’s most visible proponent in Brazil is the governor of the large and wealthy state of Sao Paulo, Joao Doria, who also happens to be one of Bolsonaro’s top opponents."

https://www.macaubusiness.com/politics-upends-search-for-covid-vaccine-in-brazil/
----
Brazil institute to import Chinese COVID-19 vaccine REJECTED by Bolsonaro.

Sao Paulo’s Butantan Institute plans to initially import Sinovac’s vaccine, which is in phase 3 trials conducted with the help of a local university and not yet approved for wider use in Brazil. Butantan would ultimately manufacture the vaccine if proven effective.

https://www.reuters.com/article/us-health-coronavirus-brazil-idUSKBN2782V6

@Noobie123 I agree with you. That makes sense.

The current share price is already below the indicative issue price of Private Placement Share ie. RM0.1780 per share. So it is in a better position now to go up.

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=107904&name=EA_GA_ATTACHMENTS

There will come a time when the operator will stop pushing the price down and push the price up instead. Its only a matter of time. Remember what goes down must eventually come up.

UAE Ministers Taking Shots to Show World Chinese Vaccine is Safe

“The first targeted audience of UAE ministers receiving doses of the Chinese-manufactured Sinopharm vaccine is domestic: it is indeed a good way to bolster public confidence, as frontline workers are also being vaccinated in large numbers in the country,” Dr. Emma Soubrier, a visiting scholar at the Arab Gulf States Institute in Washington, told The Media Line.

“Given the status of these ministers, it is also a clear message sent to the rest of the world about the level of trust invested by the UAE in the Chinese vaccine, and in the broader cooperation with China amid the coronavirus pandemic, in health technology as well as artificial intelligence and cyber capabilities,” Soubrier said.

https://themedialine.org/by-region/uae-ministers-taking-shots-to-show-world-chinese-vaccine-is-safe/

STATE OF READINESS: Emirates launches Covid-19 vaccine cargo hub

Emirates SkyCargo has already moved more than a quarter of a million tonnes of pharmaceutical cargo over the last four years but is now gearing up for potentially the largest distribution mission of its history.

https://www.logisticsmiddleeast.com/transport/36038-state-of-readiness-emirates-launches-covid-19-vaccine-cargo-hub

That eliminates Moderna and Pfizer vaccines. China has joined covax and sinopharm vaccine requires storage at standard temperature of 2-8 C

“The vaccines MOST LIKELY OFFERED BY COVAX initiative must be stored at 2 to 8 degrees Celsius.

The American drug company Pfizer is testing one of the most promising vaccine candidates. It requires storage at temperatures of minus 70 degrees Celsius. The company has designed a special carrying case for its vaccine. Pfizer has signed deals to supply the vaccine to the United States, Europe and Japan. It has also expressed an interest in Covax.

Medical freezers that go down to minus 70 degrees Celsius are rare even in U.S. and European hospitals. Many experts believe some West African countries may be best positioned. Those areas suffered through the Ebola health crisis from 2014 to 2016. Like the coronavirus vaccine, the Ebola vaccine requires very cold storage.”

https://www.google.com/amp/s/learningenglish.voanews.com/amp/storage-issues-could-leave-3-billion-without-covid-19-vaccine/5628410.html

@shark888 Dont be so sure you will be able to enter at 0.145. Unless you are the shark yourself? kekeke

Hopefully 'drastic' move will include Covid Vaccine.

"Malaysia quarantines 10,000 cops; minister says 'drastic' move needed to curb Covid-19"

https://www.malaymail.com/news/malaysia/2020/10/16/khairy-frontliners-will-get-covid-19-vaccine-first-once-its-ready/1913243

-------

"Science, Technology and Innovation Minister Khairy Jamaluddin today said that Covid-19 frontline workers will be given the priority once a viable vaccine is available.

In an interview with BFM 89.9 this morning, the Rembau MP said priority will be given to healthcare, social workers, teachers and POLICEMEN among others."

https://www.malaymail.com/news/malaysia/2020/10/16/khairy-frontliners-will-get-covid-19-vaccine-first-once-its-ready/1913243

@Noobie123 That is certainly possible.

Malaysia also has emergency use authorization pathway to allow use of unapproved medical products based on interim analysis data from phase III studies which measn emergency use may be granted even before full phase III data is available. Full approval will be granted once phase III studies is complete and full data is available.

"The products are currently in development by Sinopharm in accelerated Phase 3 trials. Due to
the urgency caused by the Covid-19 pandemic THE MALAYSIAN GOVERNMENT HAS
EXPRESSED INTEREST TO FAST-TRACK THE REGULATORY APPROVAL of the products.

Both Parties understand that the outcome of the Phase 3 trials is unsure and that the products
will require an EMERGENCY USE AUTHORIZATION by the Malaysian authorities, which Kanger is
actively pursuing."

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3099655

-------

"Recently published guidance from the Food and Drug Administration (FDA) recommends that data from phase 3 studies to support an Emergency Use Authorization (EUA) (which may result from a protocol-specified interim analysis) include a median follow-up duration of at least 2 months after completion of the full vaccination regimen.

An Emergency Use Authorization (EUA) allows use of unapproved medical products (or unapproved uses of approved medical products) to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by threat agents, such as Covid-19, in response to a declared public health emergency for which there are no adequate, approved, and available alternatives."

https://www.nejm.org/doi/full/10.1056/NEJMp2031373#:~:text=An%20EUA%20allows%20use%20of,are%20no%20adequate%2C%20approved%2C%20and

While final results are not in, data from Brazil indicated that the Sinovac vaccine is likely safe. The United Arab Emirates also is in the middle of testing the BBIBP-CorV vaccine in a Phase 3 trial, with results expected soon, just as China itself is actively testing the products.

One recent paper in the medical journal The Lancet indicated a result of “promising” and also sufficiently safe. The matter is hardly settled, but at the very least, the Chinese vaccines are not dropping out of contention. China is already administering those vaccines to its military and to some employees of state-owned enterprises

Another advantage of the Chinese vaccines is that they are designed for QUICK PRODUCTION and RAPID SCALABILITY. That could be helpful even if in purely biomedical terms they are not the most potent products.

https://themalaysianreserve.com/2020/10/27/us-should-be-working-with-china-on-a-vaccine/

https://www.bloomberg.com/opinion/articles/2020-10-25/chinese-vaccine-for-covid-19-trump-should-agree-to-test-in-u-s

@mykasih99 Ask kstar to supply some fuel to Kanger as well lol.

Fauci: Wear a Mask Even When COVID Vaccine Comes

https://www.infectioncontroltoday.com/view/fauci-wear-a-mask-even-when-covid-vaccine-comes

Hopes are rising that Chinese Covid-19 vaccines may be among the first to receive regulatory approval, but analysts say hurdles remain before China becomes a key player in the global market, even if it produces a successful vaccine.

Three Chinese vaccines are now leading the race, with the privately-owned Sinovac and state-owned China National Pharmaceutical Group (Sinopharm) both expecting interim data from their last stages of clinical trials by the end of this year.

Zhang Yuntao, vice-president of the China National Biotec Group, part of Sinopharm, said earlier that preparations for “conditional approval” assessment had already begun for its two vaccines that, once granted, would permit them to be administered on the general Chinese public.

Chinese vaccines may gain inroads overseas before they win conditional approval in China, via EULs granted by other national regulators. Last month, a Sinopharm experimental vaccine became the first Chinese Covid-19 candidate to receive an overseas emergency use licensing (EUL), from the United Arab Emirates which approved it for its frontline health workers.

“The beauty for China contributing to Covax is that the vaccines HAVE TO BE WHO PRE-QUALIFIED, which commits the Chinese companies to a standard that is actually over the international [good manufacturing practice] standard that China follows,” said Jerome Kim, director general of the International Vaccine Institute founded by the United Nations.

.....the Covid-19 candidates are developed by China’s best vaccine producers and receive more stringent scrutiny.

Sinopharm and Sinovac both have other vaccines pre-qualified by the WHO. A subsidiary of Sinopharm was the FIRST TO RECEIVE WHO prequalification for Japanese encephalitis vaccines after years of support from several UN agencies to help it meet the standard. “They know what the WHO wants,” Kim said, adding that China was supplying 80 per cent of the Japanese encephalitis vaccines in Asia.

https://www.scmp.com/news/china/science/article/3107191/can-china-become-leading-producer-covid-19-vaccines

KUALA LUMPUR: The HEALTHCARE sector is expected to receive a HIGHER budget allocation under the Budget 2021 to support Ministry of Health and other relevant ministries’ efforts in battling Covid-19.

In the "Thoughts” column on www.bernama.com, executive director of the Socio-Economic Research Centre (SERC) Lee Heng Guie said confidence in the future path of virus development and the availability of VACCINES is needed for a full recovery.

https://www.thestar.com.my/business/business-news/2020/10/26/higher-funding-for-healthcare-sector-under-budget-2021

https://foxnewssouthtexas.com/2020/10/24/people-are-traveling-across-china-in-the-hopes-of-getting-an-experimental-covid-19-vaccine-shot/

Sinovac and Sinopharm, a fellow Chinese pharmaceutical company, are conducting clinical trials of their vaccine candidates in Peru, Chile, Argentina and elsewhere in the region. A test with roughly 6,000 subjects is planned in Peru, where President Martin Vizcarra visited a hospital carrying out final-phase trials in late September.

The Chinese government said in July that it would lend $1 billion to Latin American countries for procuring vaccines. The reliance on China has become especially conspicuous among poor Caribbean nations.

https://asia.nikkei.com/Politics/International-relations/China-injects-vaccine-diplomacy-into-Latin-America

Chinese officials have said they want to make Egypt a hub for manufacturing vaccines for the African market, with a state-run drugmaker having launched a partnership with the country to conduct human trials

https://www.wsj.com/articles/covid-19-vaccine-makers-see-egypt-as-crucial-launchpad-11603707672

COVID-19 vaccines likely won't end need for masks, distancing

https://www.inforum.com/newsmd/coronavirus/6730937-COVID-19-vaccines-likely-wont-end-need-for-masks-distancing

There is a rumour that the Novavax vaccine is delayed, which has seen the stock drop some 6% in recent trade.

Novavax, Inc. (Nasdaq: NVAX), is a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, including NVX-CoV2373, the Company’s COVID-19 vaccine.

https://www.fxstreet.com/news/covid-vaccine-novavax-delay-rumours-weighing-on-sentiment-202010262001

Kanger International Bhd has roped in Zuellig Pharma Sdn Bhd and K-Star Sport Ltd to collaborate on the distribution of Covid-19 vaccines in Malaysia.

In a filing with Bursa Malaysia today, Kanger said it has entered into a memorandum of understanding (MoU) with Zuellig Pharma, the largest vaccine distributor in Malaysia and in Asia, to facilitate the import, warehousing and distribution of Covid-19 vaccines in Malaysia.

Separately, Kanger announced that it has also entered into an MoU with K-Star to appoint the latter as the sales agent of Covid-19 vaccines for private clinics in Malaysia.

https://www.theedgemarkets.com/article/kanger-ropes-more-collaborators-help-distribute-covid19-vaccines

@BigPortfolio Are you really that thick? That was yesterdays news la dumbass! Now that politics is stable, it should be okay continue.

wah

nice

Anxiously waiting for the outcome of the UMNO supreme council meeting. Hoping for the best.

@noobie123 I see. Thanks for the information.

Hope the rising number of Covid cases in Malaysia and worldwide will be resilient enough to push the price back up despite all these political uncertainties.

Are there any stocks linked to syringes in Malaysia?

Hope tomorrow will rebound. Please rebound.

Dirty politics is beyond our control. Its unfortunate but we have to live with it for now.

This week have to be very careful. Play safe, cut loss if necessary. https://www.bharian.com.my/berita/nasional/2020/10/746456/umno-buat-keputusan-malam-ini

@JK22 If you look back at my post above, i wasnt giving any advise. In fact i was SEEKING advice and finding out more about this company to see if there are anything negative that i should worry about because i was actually LOOKING into joining this counter. Surely you will have to look at a company at ALL angles be it good or bad. Otherwise, its impossible to weigh the risks.